ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Rick A. Esposito
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bräu, N.
Right arrow Articles by Simberkoff, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bräu, N.
Right arrow Articles by Simberkoff, M. S.

Ann Thorac Surg 1992;54:552-554
© 1992 The Society of Thoracic Surgeons


Articles

Cardiac valve replacement in patients infected with the human immunodeficiency virus

Norbert Bräu, MD*, Rick A. Esposito, MD, Michael S. Simberkoff, MD

Infectious Diseases Section, Medical Service, and Cardiothoracic Surgery Section, Surgical Service, Department of Veterans Affairs Medical Center, New York, New York USA

Accepted for publication December 4, 1991.

* Address reprint requests to Dr Bräu, Infectious Diseases Section, Department of Veterans Affairs Medical Center, 423 East 23rd St, New York, NY 10010.

Major surgical procedures, especially when performed under general anesthesia, can depress immunological parameters measured in vitro. Therefore concern has been expressed that operation might have an adverse effect on the immune status of individuals infected with the human immunodeficiency virus (HIV). Four HIV-positive patients without symptoms of HIV disease underwent cardiac valve replacement in consequence of infective endocarditis. After up to 15 months postoperalively, 3 patients are alive and well without signs of progressive immunodeficiency or recurrent endocarditis. One patient died of recurrent endocarditis without evidence of HIV-related disease on autopsy. Cardiac operation does not seem to accelerate HIV-related immunodeficiency.




This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
C.-A. Mestres, J. E. Chuquiure, X. Claramonte, J. Munoz, N. Benito, M. A. Castro, J. L. Pomar, and J. M. Miro
Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1)
Eur J Cardiothorac Surg, June 1, 2003; 23(6): 1007 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Aris, J. Pomar, and E. Saura
Cardiopulmonary bypass in HIV-positive patients
Ann. Thorac. Surg., May 1, 1993; 55(5): 1104 - 1108.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.